TLRY Tilray Inc

USD 2.48 0.17 7.359307
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.48

+0.17 (+7.36)%

USD 1.74B

0.06B

USD 2.46(-0.71%)

USD 0.00 (-100.00%)

Icon

TLRY

Tilray Inc (USD)
COMMON STOCK | NSD
USD 2.48
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.74B

USD 0.00 (-100.00%)

USD 2.48

Tilray Inc (TLRY) Stock Forecast

USD 2.46
(-0.71%)

Based on the Tilray Inc stock forecast from 3 analysts, the average analyst target price for Tilray Inc is USD 2.46 over the next 12 months. Tilray Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Tilray Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Tilray Inc’s stock price was USD 2.48. Tilray Inc’s stock price has changed by +25.25% over the past week, +37.02% over the past month and -4.98% over the last year.

No recent analyst target price found for Tilray Inc
No recent average analyst rating found for Tilray Inc

Company Overview Tilray Inc

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Dis...Read More

https://www.tilray.com

265 Talbot Street West, Leamington, ON, Canada, N8H 5L4

1,600

December

USD

USA

Adjusted Closing Price for Tilray Inc (TLRY)

Loading...

Unadjusted Closing Price for Tilray Inc (TLRY)

Loading...

Share Trading Volume for Tilray Inc Shares

Loading...

Compare Performance of Tilray Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for TLRY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Tilray Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc +2.84 (+1.71%) USD79.01B 34.04 22.84

ETFs Containing TLRY

Symbol Name TLRY's Weight Expense Ratio Price(Change) Market Cap
HMMJ:CA
Horizons Marijuana Life S.. 11.09 % 0.00 % +0.42 (+3.90%) USD0.08B

Frequently Asked Questions About Tilray Inc (TLRY) Stock

Based on ratings from 3 analysts Tilray Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on TLRY's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for TLRY is USD 2.46 over the next 12 months. The maximum analyst target price is USD 3.1 while the minimum anlayst target price is USD 2.25.

TLRY stock's Price/Earning ratio is 7.34. Our analysis grades TLRY stock's Price / Earning ratio at D+. This means that TLRY stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this TLRY may be fairly valued for its sector

The last closing price of TLRY's stock was USD 2.48.

The most recent market capitalization for TLRY is USD 1.74B.

Based on targets from 3 analysts, the average taret price for TLRY is projected at USD 2.46 over the next 12 months. This means that TLRY's stock price may go down by -0.71% over the next 12 months.

Following are ETFs with the highest allocation to Tilray Inc's stock :

HMMJ:CA

As per our most recent records Tilray Inc has 1,600 Employees.

Tilray Inc's registered address is 265 Talbot Street West, Leamington, ON, Canada, N8H 5L4. You can get more information about it from Tilray Inc's website at https://www.tilray.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...